Fecundis
2 known investors
Find your way into Fecundis
471 people in our graph share verified history with the Fecundis team — schools, employers, funds. One of them is your warm intro.
Arturo Litvinunlockedknows Matías Gómez Elías · together at University of Buenos Aires (overlapped)
knows the team · via University of Buenos Aires
×2knows the team · via University of Massachusetts Amherst
knows the team · via Universidad de León
×4knows the team · via Universidad Complutense de Madrid
×2knows the team · via EAE Business School
Fecundis is a biotechnology company developing sperm-centered technologies for assisted reproduction, including HyperSperm, a sequential-step kit that recreates physiological sperm capacitation in vitro for IVF and ICSI. Its products are aimed at IVF laboratories and fertility clinics to improve sperm function, embryo quality, and ART outcomes.
Founders & leadership
MB
Mariano BuffoneinCo-founder & CSOMariano Buffone is co-founder and Chief Scientific Officer of Fecundis, a biotechnology company developing sperm-centered technologies for assisted reproduction. He specializes in the molecular and cellular mechanisms of sperm function and brings expertise in reproductive biology and translational science to the field.
DK
Dario KrapfinCo-founder & CSODario Krapf is co-founder and chief scientific officer of Fecundis, a biotechnology company developing sperm-centered technologies for assisted reproduction. He has expertise in sperm physiology and molecular pathways related to fertilization competence.
AR
Arina RogozinainCEOArina Rogozina is CEO of Fecundis, a biotechnology company developing sperm-centered technologies for assisted reproduction. She has spent 15+ years in biotech and healthcare leadership roles focused on reproductive technologies and international expansion, and co-founded CAPTCHAT, a healthcare communication platform for fertility clinics.
MG
Matías Gómez ElíasinCOOMatías Gómez Elías holds a PhD in Biological Chemistry and has conducted over a decade of research on sperm physiology and fertilization, including work on oocyte micromanipulation techniques at the University of Massachusetts Amherst as a Fulbright fellow. He is COO and R&D Manager at Fecundis and is pursuing an MBA.
Investors · 2
Funding
SEC filings, press & company announcements- Undisclosed amountseed funding roundOct 2024Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Fecundis do?
- Fecundis is a biotechnology company developing sperm-centered technologies for assisted reproduction, including HyperSperm, a sequential-step kit that recreates physiological sperm capacitation in vitro for IVF and ICSI. Its products are aimed at IVF laboratories and fertility clinics to improve sperm function, embryo quality, and ART outcomes.
- Who founded Fecundis?
- Fecundis was founded by Mariano Buffone, Dario Krapf.
- Who are Fecundis's investors?
- Fecundis's investors include Capital Cell, GRIDX.